sglt2 glp 1 combination Influence of therapy with inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes A retrospective analysis of combination
Description
Martel et al
Everyone is allowed to have their own opinion
Executive Summary Introduction
Learn 5 reasons including Metabolic Adaptation, Dosing Issues, Hormonal Resistance, and Lean Mass Loss.
Beyond their roles in diabetes treatment, AGIs have shown potential in extending lifespan and effectively treating aging-related diseases by modulating oxidative stress, gut microbiota, inflammatory responses, and nutrient-sensing pathways
The FDA has approved three GLP-1 receptor agonist drugs for weight loss
